Benzinga | Jul 1, 2021 04:58AM EDT

Raymond James Initiates Coverage On Agios Pharmaceuticals with Market Perform Rating

Raymond James analyst Danielle Brill initiates coverage on Agios Pharmaceuticals (NASDAQ:AGIO) with a Market Perform rating.